|
1
|
Ambrosy AP, Fonarow GC, Butler J, Chioncel
O, Greene SJ, Vaduganathan M, Nodari S, Lam CSP, Sato N, Shah AN
and Gheorghiade M: The global health and economic burden of
hospitalizations for heart failure: Lessons learned from
hospitalized heart failure registries. J Am Coll Cardiol.
63:1123–1133. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zhang Y, Bauersachs J and Langer HF:
Immune mechanisms in heart failure. Eur J Heart Fail. 19:1379–1389.
2017.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Zhou B and Tian R: Mitochondrial
dysfunction in pathophysiology of heart failure. J Clin Invest.
128:3716–3726. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hein S, Arnon E, Kostin S, Schönburg M,
Elsässer A, Polyakova V, Bauer EP, Klövekorn WP and Schaper J:
Progression from compensated hypertrophy to failure in the
pressure-overloaded human heart: Structural deterioration and
compensatory mechanisms. Circulation. 107:984–991. 2003.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Neubauer S: The failing heart-an engine
out of fuel. N Engl J Med. 356:1140–1151. 2007.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ehmke H: The Sigma-1 receptor: A molecular
chaperone for the heart and the soul? Cardiovasc Res. 93:6–7.
2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Bhuiyan MS and Fukunaga K: Targeting
Sigma-1 receptor signaling by endogenous ligands for
cardioprotection. Expert Opin Ther Targets. 15:145–155.
2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hayashi T and Su TP: Sigma-1 receptor
chaperones at the ER-mitochondrion interface regulate Ca(2+)
signaling and cell survival. Cell. 131:596–610. 2007.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bhuiyan MS, Tagashira H, Shioda N and
Fukunaga K: Targeting Sigma-1 receptor with fluvoxamine ameliorates
pressure-overload-induced hypertrophy and dysfunctions. Expert Opin
Ther Targets. 14:1009–1022. 2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ela C, Barg J, Vogel Z, Hasin Y and Eilam
Y: Sigma receptor ligands modulate contractility, Ca++
influx and beating rate in cultured cardiac myocytes. J Pharmacol
Exp Ther. 269:1300–1309. 1994.PubMed/NCBI
|
|
11
|
Marriott KS, Prasad M, Thapliyal V and
Bose HS: σ-1 receptor at the mitochondrial-associated endoplasmic
reticulum membrane is responsible for mitochondrial metabolic
regulation. J Pharmacol Exp Ther. 343:578–586. 2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tagashira H, Bhuiyan S, Shioda N, Hasegawa
H, Kanai H and Fukunaga K: Sigma1-receptor stimulation with
fluvoxamine ameliorates transverse aortic constriction-induced
myocardial hypertrophy and dysfunction in mice. Am J Physiol Heart
Circ Physiol. 299:H1535–H1545. 2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tagashira H, Bhuiyan MS and Fukunaga K:
Diverse regulation of IP3 and ryanodine receptors by pentazocine
through σ1-receptor in cardiomyocytes. Am J Physiol Heart Circ
Physiol. 305:H1201–H1212. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Li XQ, He JC, Huang PX and Cao XB: Chinese
medicine syndromes in congestive heart failure: A literature study
and retrospective analysis of clinical cases. Chin J Integr Med.
22:738–744. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lin SS, Liu CX, Zhang JH, Wang XL and Mao
JY: Efficacy and safety of oral Chinese patent medicine combined
with conventional therapy for heart failure: An overview of
systematic reviews. Evid Based Complement Alternat Med.
2020(8620186)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chen YY, Li Q, Pan CS, Yan L, Fan JY, He
K, Sun K, Liu YY, Chen QF, Bai Y, et al: QiShenYiQi Pills, a
compound in Chinese medicine, protects against pressure
overload-induced cardiac hypertrophy through a multi-component and
multi-target mode. Sci Rep. 5(11802)2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wang Y, Fu M, Wang J, Zhang J, Han X, Song
Y, Fan Y, Hu K, Zhou J and Ge J: Qiliqiangxin improves cardiac
function through regulating energy metabolism via HIF-1α-dependent
and independent mechanisms in heart failure rats after acute
myocardial infarction. Biomed Res Int. 2020(1276195)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lou LX, Wu AM, Zhang DM, Wu SX, Gao YH,
Nie B, Zhao MJ, Lv XY, Jin QS, Zhao YZ, et al: Yiqi Huoxue recipe
improves heart function through inhibiting apoptosis related to
endoplasmic reticulum stress in myocardial infarction model of
rats. Evid Based Complement Alternat Med.
2014(745919)2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Li J, Guan XK and Liu RX: Role of Chinese
herbal medicines in regulation of energy metabolism in treating
cardiovascular diseases. Chin J Integr Med. 25:307–315.
2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhang J, Wei C, Wang H, Tang S, Jia Z,
Wang L, Xu D and Wu Y: Protective effect of qiliqiangxin capsule on
energy metabolism and myocardial mitochondria in pressure overload
heart failure rats. Evid Based Complement Alternat Med.
2013(378298)2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tang DX, Zhao HP, Pan CS, Liu YY, Wei XH,
Yang XY, Chen YY, Fan JY, Wang CS, Han JY and Li PP: QiShenYiQi
Pills, a compound Chinese medicine, ameliorates doxorubicin-induced
myocardial structure damage and cardiac dysfunction in rats. Evid
Based Complement Alternat Med. 2013(480597)2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lu Y, Li S, Wu H, Bian Z, Xu J, Gu C, Chen
X and Yang D: Beneficial effects of astragaloside IV against
angiotensin II-induced mitochondrial dysfunction in rat vascular
smooth muscle cells. Int J Mol Med. 36:1223–1232. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Luan A, Tang F, Yang Y, Lu M, Wang H and
Zhang Y: Astragalus polysaccharide attenuates isoproterenol-induced
cardiac hypertrophy by regulating TNF-α-PGC-1α signaling mediated
energy biosynthesis. Environ Toxicol Pharmacol. 39:1081–1090.
2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tsai SY, Hayashi T, Mori T and Su TP:
Sigma-1 receptor chaperones and diseases. Cent Nerv Syst Agents Med
Chem. 9:184–189. 2009.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Taylor CB, Youngblood ME, Catellier D,
Veith RC, Carney RM, Burg MM, Kaufmann PG, Shuster J, Mellman T,
Blumenthal JA, et al: Effects of antidepressant medication on
morbidity and mortality in depressed patients after myocardial
infarction. Arch Gen Psychiatry. 62:792–798. 2005.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Abdullah CS, Alam S, Aishwarya R, Miriyala
S, Panchatcharam M, Bhuiyan MAN, Peretik JM, Orr AW, James J,
Osinska H, et al: Cardiac dysfunction in the sigma 1 receptor
knockout mouse associated with impaired mitochondrial dynamics and
bioenergetics. J Am Heart Assoc. 7(e009775)2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tagashira H, Bhuiyan MS, Shioda N and
Fukunaga K: Fluvoxamine rescues mitochondrial Ca2+
transport and ATP production through σ(1)-receptor in hypertrophic
cardiomyocytes. Life Sci. 95:89–100. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Su TP, Hayashi T, Maurice T, Buch S and
Ruoho AE: The Sigma-1 receptor chaperone as an inter-organelle
signaling modulator. Trends Pharmacol Sci. 31:557–566.
2010.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kushnir A, Wajsberg B and Marks AR:
Ryanodine receptor dysfunction in human disorders. Biochim Biophys
Acta Mol Cell Res. 1865:1687–1697. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Rousseaux CG and Greene SF: Sigma
receptors [sigmaRs]: Biology in normal and diseased states. J
Recept Signal Transduct Res. 36:327–388. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Bao Q, Zhao M, Chen L, Wang Y, Wu S, Wu W
and Liu X: MicroRNA-297 promotes cardiomyocyte hypertrophy via
targeting Sigma-1 receptor. Life Sci. 175:1–10. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Liu Y, Hu Y, Qiukai E, Zuo J, Yang L and
Liu W: Salvianolic acid B inhibits mitochondrial dysfunction by
up-regulating mortalin. Sci Rep. 7(43097)2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Kwan KK, Huang Y, Leung KW, Dong TT and
Tsim KW: Danggui Buxue Tang, a Chinese herbal decoction containing
astragali radix and angelicae sinensis radix, modulates
mitochondrial bioenergetics in cultured cardiomyoblasts. Front
Pharmacol. 10(614)2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Jin HJ and Li CG: Tanshinone IIA and
cryptotanshinone Prevent mitochondrial dysfunction in
hypoxia-induced H9c2 cells: Association to mitochondrial ROS,
intracellular nitric oxide, and calcium levels. Evid Based
Complement Alternat Med. 2013(610694)2013.PubMed/NCBI View Article : Google Scholar
|
